Elisa Attkisson
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Cell death mechanisms and regulation
- PI3K/AKT/mTOR signaling in cancer
Papers in
-
- Histone Deacetylase Inhibitors Research 3
- Protein Degradation and Inhibitors 2
- Ion channel regulation and function 1
- RNA Interference and Gene Delivery 1
- Cell death mechanisms and regulation 1
-
- Chronic Myeloid Leukemia Treatments 3
- Acute Myeloid Leukemia Research 2
- Co-authors
- Steven Grant (5 shared papers)Andrea Ferreira‐Gonzalez (2 shared papers)D. Clive Williams (2 shared papers)Mohamed Rahmani (2 shared papers)Mandy Mayo Aust (2 shared papers)Sompong Sombati (2 shared papers)Laxmikant S. Deshpande (2 shared papers)Robert J. DeLorenzo (2 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Cancer Research (2 papers)European Journal of Pharmacology (1 paper)Blood (1 paper)Neuroscience Letters (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
Elisa Attkisson
7 papers receiving 432 citations
Peers
Comparison fields: 5 of 66
- Hematology 107
- Molecular Biology 287
- Cellular and Molecular Neuroscience 72
- Genetics 38
- Developmental Neuroscience 12
Countries citing papers authored by Elisa Attkisson
This map shows the geographic impact of Elisa Attkisson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Attkisson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Attkisson more than expected).
Fields of papers citing papers by Elisa Attkisson
This network shows the impact of papers produced by Elisa Attkisson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Attkisson. The network helps show where Elisa Attkisson may publish in the future.
Co-authors
The 22 scholars most cited alongside Elisa Attkisson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 128 | |
| 2 | 2012 | 90 | |
| 3 | 2008 | 73 | |
| 4 | 2011 | 70 | |
| 5 | 2008 | 54 | |
| 6 | 2012 | 22 | |
| 7 | 2011 | 1 |
About Elisa Attkisson
Elisa Attkisson is a scholar working on Molecular Biology, Hematology, Epidemiology, Infectious Diseases and Cellular and Molecular Neuroscience, having authored 7 papers that have together received 438 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Protein Degradation and Inhibitors (2 papers), Acute Myeloid Leukemia Research (2 papers), Ion channel regulation and function (1 paper), Traumatic Brain Injury and Neurovascular Disturbances (1 paper), RNA Interference and Gene Delivery (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Hematology (107 citations), Molecular Biology (287 citations), Cellular and Molecular Neuroscience (72 citations), Genetics (38 citations) and Developmental Neuroscience (12 citations). Elisa Attkisson has collaborated with scholars based in United States and France. Frequent co-authors include Steven Grant, Andrea Ferreira‐Gonzalez, D. Clive Williams, Mohamed Rahmani, Mandy Mayo Aust, Sompong Sombati, Laxmikant S. Deshpande, Robert J. DeLorenzo, Robert E. Blair and Ali Mian. Their work appears in journals such as Clinical Cancer Research, Cancer Research, European Journal of Pharmacology, Blood and Neuroscience Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.